Peter Greenleaf
2021 - Aurinia Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $506,734 |
|---|---|
| Salary | $723,905 |
| Other | $9,750 |
| Total | $1,240,389 |
Greenleaf received $723.9K in salary, accounting for 58% of the total pay in 2021.
Greenleaf also received $506.7K in non-equity incentive plan and $9.8K in other compensation.
Rankings
In 2021, Peter Greenleaf's compensation ranked 7,999th out of 12,412 executives tracked by ExecPay. In other words, Greenleaf earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,999 out of 12,412 | 36th |
Division Manufacturing | 3,536 out of 5,498 | 36th |
Major group Chemicals And Allied Products | 1,572 out of 2,374 | 34th |
Industry group Drugs | 1,397 out of 2,095 | 33rd |
Industry Pharmaceutical Preparations | 1,035 out of 1,542 | 33rd |
Pay ratio
| Peter Greenleaf's Pay | $1,240,389 |
|---|---|
| Median Employee's Pay | $255,489 |
| Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Peter Greenleaf was $1,240,389.
The annual total compensation of the median employee at Aurinia Pharmaceuticals was $255,489.
The ratio of Peter Greenleaf's pay to the pay of median employee was therefore 5 to one.
Greenleaf's colleagues
We found four more compensation records of executives who worked with Peter Greenleaf at Aurinia Pharmaceuticals in 2021.
News
April 18, 2022
May 10, 2021
April 28, 2020
June 19, 2019